0001140361-15-021741.txt : 20150526
0001140361-15-021741.hdr.sgml : 20150525
20150526180746
ACCESSION NUMBER: 0001140361-15-021741
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150521
FILED AS OF DATE: 20150526
DATE AS OF CHANGE: 20150526
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: THORATEC CORP
CENTRAL INDEX KEY: 0000350907
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 942340464
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1228
BUSINESS ADDRESS:
STREET 1: 6035 STONERIDGE DR
CITY: PLEASANTON
STATE: CA
ZIP: 94588
BUSINESS PHONE: 9258478600
MAIL ADDRESS:
STREET 1: 6035 STONERIDGE DR
CITY: PLEASANTON
STATE: CA
ZIP: 94588
FORMER COMPANY:
FORMER CONFORMED NAME: THORATEC CARDIOSYSTEMS INC
DATE OF NAME CHANGE: 20010220
FORMER COMPANY:
FORMER CONFORMED NAME: THORATEC LABORATORIES CORP
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DIMICK NEIL F
CENTRAL INDEX KEY: 0001248380
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-49798
FILM NUMBER: 15890537
MAIL ADDRESS:
STREET 1: 25913 RICH SPRINGS CIRCLE
STREET 2: C/O WEBMD CORP
CITY: LA GUNS HILLS
STATE: CA
ZIP: 92653
FORMER NAME:
FORMER CONFORMED NAME: DIMICK NEIL F
DATE OF NAME CHANGE: 20030626
4
1
doc1.xml
FORM 4
X0306
4
2015-05-21
0
0000350907
THORATEC CORP
THOR
0001248380
DIMICK NEIL F
6035 STONERIDGE DRIVE
PLEASANTON
CA
94588
1
0
0
0
Common Stock
2015-05-21
4
S
0
5505
44.74
D
35003
D
Common Stock
2015-05-26
4
S
0
2468
45.4331
D
32535
D
Common Stock
2015-05-26
4
S
0
200
45.9150
D
32335
D
Shares of Common Stock sold pursuant to a Sales Plan established by the Reporting Person on September 11, 2013, which Sales Plan is intended to comply with the requirements of Rule 10b5-1(c)(1) under the Securities Exchange Act 1934, as amended.
This transaction was executed in multiple trades in prices ranging from $44.50 to $45.20. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades in prices ranging from $44.85 to $45.82. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades in prices ranging from $45.91 to $45.92. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
/s/ David A. Lehman, Attorney-In-Fact
2015-05-26